These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1394053)

  • 1. Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
    Kreissman SG; Gelber RD; Cohen HJ; Clavell LA; Leavitt P; Sallan SE
    Cancer; 1992 Oct; 70(8):2208-13. PubMed ID: 1394053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
    Vrooman LM; Neuberg DS; Stevenson KE; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Larsen EC; Laverdière C; Michon B; Schorin M; Schwartz CL; Cohen HJ; Lipshultz SE; Silverman LB; Sallan SE
    Eur J Cancer; 2011 Jun; 47(9):1373-9. PubMed ID: 21514146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
    N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
    Relling MV; Yanishevski Y; Nemec J; Evans WE; Boyett JM; Behm FG; Pui CH
    Leukemia; 1998 Mar; 12(3):346-52. PubMed ID: 9529129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Winick NJ; McKenna RW; Shuster JJ; Schneider NR; Borowitz MJ; Bowman WP; Jacaruso D; Kamen BA; Buchanan GR
    J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
    Barry EV; Vrooman LM; Dahlberg SE; Neuberg DS; Asselin BL; Athale UH; Clavell LA; Larsen EC; Moghrabi A; Samson Y; Schorin MA; Cohen HJ; Lipshultz SE; Sallan SE; Silverman LB
    J Clin Oncol; 2008 Mar; 26(7):1106-11. PubMed ID: 18309945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
    Rae C; Furlong W; Feeny D; Couchman R; Silverman L; Sallan S; Laverdiere C; Clavell L; Michon B; Kelly K; Larsen E; Pullenayegum E; Athale U; Barr R
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):580-587. PubMed ID: 29901560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
    Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.
    Ishida Y; Maeda M; Urayama KY; Kiyotani C; Aoki Y; Kato Y; Goto S; Sakaguchi S; Sugita K; Tokuyama M; Nakadate N; Ishii E; Tsuchida M; Ohara A;
    Br J Haematol; 2014 Jan; 164(1):101-12. PubMed ID: 24116892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
    Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
    JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
    J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukemia in association with Langerhans cell histiocytosis.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
    Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The childhood leukemias.
    Colby-Graham MF; Chordas C
    J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.
    Brown CA; Youlden DR; Aitken JF; Moore AS
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27410. PubMed ID: 30183136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
    Gupta S; Sutradhar R; Li Q; Athale U; Bassal M; Breakey V; Gibson PJ; Patel S; Silva M; Zabih V; Pechlivanoglou P; Pole JD; Mittmann N
    Eur J Cancer; 2021 Jul; 151():126-135. PubMed ID: 33979728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
    Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
    J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.